全文获取类型
收费全文 | 2036篇 |
免费 | 192篇 |
出版年
2022年 | 30篇 |
2021年 | 72篇 |
2020年 | 31篇 |
2019年 | 47篇 |
2018年 | 50篇 |
2017年 | 26篇 |
2016年 | 54篇 |
2015年 | 118篇 |
2014年 | 108篇 |
2013年 | 109篇 |
2012年 | 163篇 |
2011年 | 164篇 |
2010年 | 79篇 |
2009年 | 69篇 |
2008年 | 91篇 |
2007年 | 103篇 |
2006年 | 99篇 |
2005年 | 87篇 |
2004年 | 57篇 |
2003年 | 63篇 |
2002年 | 58篇 |
2001年 | 31篇 |
2000年 | 25篇 |
1999年 | 41篇 |
1998年 | 11篇 |
1997年 | 11篇 |
1996年 | 10篇 |
1992年 | 22篇 |
1991年 | 14篇 |
1990年 | 9篇 |
1989年 | 17篇 |
1988年 | 13篇 |
1987年 | 12篇 |
1986年 | 19篇 |
1985年 | 10篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1981年 | 9篇 |
1980年 | 10篇 |
1979年 | 18篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 23篇 |
1975年 | 14篇 |
1974年 | 10篇 |
1973年 | 30篇 |
1972年 | 12篇 |
1969年 | 13篇 |
1968年 | 10篇 |
1966年 | 10篇 |
排序方式: 共有2228条查询结果,搜索用时 24 毫秒
91.
92.
Vikas Ghai David Baxter Xiaogang Wu Taek‐Kyun Kim Johanna Kuusisto Markku Laakso Tom Connolly Yong Li Patricia Andrade‐Gordon Kai Wang 《Journal of cellular and molecular medicine》2019,23(4):2753-2768
Type 2 Diabetes Mellitus (T2DM) is the most prevalent form of diabetes in the USA, thus, the identification of biomarkers that could be used to predict the progression from prediabetes to T2DM would be greatly beneficial. Recently, circulating RNA including microRNAs (miRNAs) present in various body fluids have emerged as potential biomarkers for various health conditions, including T2DM. Whereas studies that examine the changes of miRNA spectra between healthy controls and T2DM individuals have been reported, the goal of this study is to conduct a baseline comparison of prediabetic individuals who either progress to T2DM, or remain prediabetic. Using an advanced small RNA sequencing library construction method that improves the detection of miRNA species, we identified 57 miRNAs that showed significant concentration differences between progressors (progress from prediabetes to T2DM) and non‐progressors. Among them, 26 have been previously reported to be associated with T2DM in either body fluids or tissue samples. Some of the miRNAs identified were also affected by obesity. Furthermore, we identified miRNA panels that are able to discriminate progressors from non‐progressors. These results suggest that upon further validation these miRNAs may be useful to predict the risk of conversion to T2DM from prediabetes. 相似文献
93.
94.
Laura L. Baxter Dawn E. Watkins‐Chow William J. Pavan Stacie K. Loftus 《Pigment cell & melanoma research》2019,32(3):348-358
Over the past century, studies of human pigmentary disorders along with mouse and zebrafish models have shed light on the many cellular functions associated with visible pigment phenotypes. This has led to numerous genes annotated with the ontology term “pigmentation” in independent human, mouse, and zebrafish databases. Comparisons among these datasets revealed that each is individually incomplete in documenting all genes involved in integument‐based pigmentation phenotypes. Additionally, each database contained inherent species‐specific biases in data annotation, and the term “pigmentation” did not solely reflect integument pigmentation phenotypes. This review presents a comprehensive, cross‐species list of 650 genes involved in pigmentation phenotypes that was compiled with extensive manual curation of genes annotated in OMIM, MGI, ZFIN, and GO. The resulting cross‐species list of genes both intrinsic and extrinsic to integument pigment cells provides a valuable tool that can be used to expand our knowledge of complex, pigmentation‐associated pathways. 相似文献
95.
Andrew J. Ambrose Christopher J. Zerio Jared Sivinski Cody J. Schmidlin Taoda Shi Alison B. Ross Kimberly J. Widrick Steven M. Johnson Donna D. Zhang Eli Chapman 《Bioorganic & medicinal chemistry letters》2019,29(14):1689-1693
Glucose-regulated protein 78 (GRP78) is the ER resident 70 kDa heat shock protein 70 (HSP70) and has been hypothesized to be a therapeutic target for various forms of cancer due to its role in mitigating proteotoxic stress in the ER, its elevated expression in some cancers, and the correlation between high levels for GRP78 and a poor prognosis. Herein we report the development and use of a high throughput fluorescence polarization-based peptide binding assay as an initial step toward the discovery and development of GRP78 inhibitors. This assay was used in a pilot screen to discover the anti-infective agent, hexachlorophene, as an inhibitor of GRP78. Through biochemical characterization we show that hexachlorophene is a competitive inhibitor of the GRP78-peptide interaction. Biological investigations showed that this molecule induces the unfolded protein response, induces autophagy, and leads to apoptosis in a colon carcinoma cell model, which is known to be sensitive to GRP78 inhibition. 相似文献
96.
Mckayla Stevens Sanofar Abdeen Nilshad Salim Anne-Marie Ray Alex Washburn Siddhi Chitre Jared Sivinski Yangshin Park Quyen Q. Hoang Eli Chapman Steven M. Johnson 《Bioorganic & medicinal chemistry letters》2019,29(9):1106-1112
All living organisms contain a unique class of molecular chaperones called 60?kDa heat shock proteins (HSP60 – also known as GroEL in bacteria). While some organisms contain more than one HSP60 or GroEL isoform, at least one isoform has always proven to be essential. Because of this, we have been investigating targeting HSP60 and GroEL chaperonin systems as an antibiotic strategy. Our initial studies focused on applying this antibiotic strategy for treating African sleeping sickness (caused by Trypanosoma brucei parasites) and drug-resistant bacterial infections (in particular Methicillin-resistant Staphylococcus aureus – MRSA). Intriguingly, during our studies we found that three known antibiotics – suramin, closantel, and rafoxanide – were potent inhibitors of bacterial GroEL and human HSP60 chaperonin systems. These findings prompted us to explore what other approved drugs, natural products, and known bioactive molecules might also inhibit HSP60 and GroEL chaperonin systems. Initial high-throughput screening of 3680 approved drugs, natural products, and known bioactives identified 161 hit inhibitors of the Escherichia coli GroEL chaperonin system (4.3% hit rate). From a purchased subset of 60 hits, 29 compounds (48%) re-confirmed as selective GroEL inhibitors in our assays, all of which were nearly equipotent against human HSP60. These findings illuminate the notion that targeting chaperonin systems might be a more common occurrence than we previously appreciated. Future studies are needed to determine if the in vivo modes of action of these approved drugs, natural products, and known bioactive molecules are related to GroEL and HSP60 inhibition. 相似文献
97.
Seth M. Rudman Jared M. Goos Joseph B. Burant Kevin V. Brix Taylor C. Gibbons Colin J. Brauner Punidan D. Jeyasingh 《Ecology letters》2019,22(4):645-653
Evidence that organisms evolve rapidly enough to alter ecological dynamics necessitates investigation of the reciprocal links between ecology and evolution. Data that link genotype to phenotype to ecology are needed to understand both the process and ecological consequences of rapid evolution. Here, we quantified the suite of elements in individuals (i.e., ionome) and differences in the fluxes of key nutrients across populations of threespine stickleback. We find that allelic variation associated with freshwater adaptation that controls bony plating is associated with changes in the ionome and nutrient recycling. More broadly, we find that adaptation of marine stickleback to freshwater conditions shifts the ionomes of natural populations and populations raised in common gardens. In both cases ionomic divergence between populations was primarily driven by differences in trace elements rather than elements typically associated with bone. These findings demonstrate the utility of ecological stoichiometry and the importance of ionome‐wide data in understanding eco‐evolutionary dynamics. 相似文献
98.
99.
Janina V. Pearce Jared S. Farrar Joseph C. Lownik Bin Ni Shanshan Chen Tiffany W. Kan Francesco S. Celi 《Biochemistry and Biophysics Reports》2019
Breast cancer remains a substantial clinical problem worldwide, and cancer-associated cachexia is a condition associated with poor prognosis in this and other malignancies. Adipose tissue is involved in the development and progression of cancer-associated cachexia, but its various roles and mechanisms of action are not completely defined, especially as it relates to breast cancer. Interleukin 6 has been implicated in several mechanisms contributing to increased breast cancer tumorigenesis, as well as a net-negative energy balance and cancer-associated cachexia via adipose tissue remodeling in other models of cancer; however, its potential role in breast cancer-associated white adipose browning has not been explored. In this study, we demonstrate localized white adipose tissue browning in a spontaneous model of murine mammary cancer. We then used an in vitro murine adipocyte culture system with the E0771 and 4T1 cell lines as models of breast cancer. We demonstrate that while the E0771 and 4T1 secretomes and cross-talk with white adipocytes alter white adipocyte mRNA expression, they do not directly induce white adipocyte browning. Additionally, we show that neither exogenous administration of interleukin 6 alone or with its soluble receptor directly induce white adipocyte browning. Together, these results demonstrate that neither the E0771 or 4T1 murine breast cancer cell lines, nor interleukin 6, directly cause browning of cultured white adipocytes. This suggests that their roles in adipose tissue remodeling are more complex and indirect in nature. 相似文献
100.
Ordway JM Budiman MA Korshunova Y Maloney RK Bedell JA Citek RW Bacher B Peterson S Rohlfing T Hall J Brown R Lakey N Doerge RW Martienssen RA Leon J McPherson JD Jeddeloh JA 《PloS one》2007,2(12):e1314
Recent data have revealed that epigenetic alterations, including DNA methylation and chromatin structure changes, are among the earliest molecular abnormalities to occur during tumorigenesis. The inherent thermodynamic stability of cytosine methylation and the apparent high specificity of the alterations for disease may accelerate the development of powerful molecular diagnostics for cancer. We report a genome-wide analysis of DNA methylation alterations in breast cancer. The approach efficiently identified a large collection of novel differentially DNA methylated loci (approximately 200), a subset of which was independently validated across a panel of over 230 clinical samples. The differential cytosine methylation events were independent of patient age, tumor stage, estrogen receptor status or family history of breast cancer. The power of the global approach for discovery is underscored by the identification of a single differentially methylated locus, associated with the GHSR gene, capable of distinguishing infiltrating ductal breast carcinoma from normal and benign breast tissues with a sensitivity and specificity of 90% and 96%, respectively. Notably, the frequency of these molecular abnormalities in breast tumors substantially exceeds the frequency of any other single genetic or epigenetic change reported to date. The discovery of over 50 novel DNA methylation-based biomarkers of breast cancer may provide new routes for development of DNA methylation-based diagnostics and prognostics, as well as reveal epigenetically regulated mechanism involved in breast tumorigenesis. 相似文献